BioCentury | Mar 27, 2021
Translation in Brief

Lentigen’s trispecific CAR Ts; plus a bispecific antiviral COVID-19 mAb, Wild Biotech, Kancera and more

...The mAb —developed by scientists from the Institute for Research in Biomedicine...
...Vascular endothelial growth factor C Danielle Golovin AZD8797, KAND567, KAN0440567 Institute for Research in Biomedicine Academy...
BioCentury | Jun 16, 2020
Finance

Barcelona’s Ona takes aim at metastasis with €30M series A

...program can be first in class. Based on research by co-founder Salvador Aznar-Benitah at the Institute for Research in Biomedicine...
BioCentury | Mar 14, 2020
Product Development

AbCellera, Vir find partners for COVID-19 mAb manufacturing capacity

...proven itself in the fight against another emerging pathogen, Ebola. Teams at Humabs and the Institute for Research in Biomedicine...
BioCentury | Jul 11, 2019
Targets & Mechanisms

The tumor stroma rises as the newest source of immuno-oncology targets

...immune and stromal cellular players in this space,” she said. A separate team from the Institute for Research in Biomedicine...
...NYSE:LLY), Indianapolis, Ind. Genentech Inc., South San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Institute for Research in Biomedicine...
BioCentury | Mar 19, 2019
Distillery Therapeutics

RSV F protein-based nanoparticle vaccine for RSV infection

...Marcandalli, J. et al. Cell ; published online Mar. 7, 2019 doi:10.1016/j.cell.2019.01.046 CONTACT: Laurent Perez, Institute for Research in Biomedicine...
...Switzerland email: laurent.perez@irb.usi.ch CONTACT: Neil P. King, University of Washington, Seattle, Wash. email: neilking@uw.edu Claire Quang Icosavax Inc. Institute for Research in Biomedicine University...
BioCentury | Feb 1, 2019
Clinical News

NIAID says its Ebola therapy is safe

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
BioCentury | Jan 25, 2019
Clinical News

NIAID says its Ebola therapy is safe

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
BioCentury | Dec 6, 2018
Translation in Brief

Opening chromatin: long-term detriment?

...An Institute for Research in Biomedicine team has shown increasing chromatin accessibility in cancer could promote tumor aggressiveness, not reduce...
...and Technology. Sandi Wong, Staff Writer Barcelona Institute of Science and Technology Euchromatic histone-lysine N-methyltransferase 2 (EHMT2) (G9A) Skin cancer chromatin epigenetics Institute for Research in Biomedicine IRB...
BioCentury | Nov 30, 2018
Clinical News

Fauci details goals of new Ebola trial

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
...Status: Phase II start Milestone: NA Steve Usdin GS-5734 mAb114 REGN3470-3471-3479 VSV-EBOV (V920, BPSC1001, rVSV-EBOV, rVSV-ZEBOV-GP, VSV-ZEBOV) Zmapp Gilead Sciences Inc. Humabs BioMed S.A. Institute for Research in Biomedicine Mapp...
BioCentury | Nov 26, 2018
Clinical News

Fauci details goals of new Ebola trial

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
Items per page:
1 - 10 of 26
BioCentury | Mar 27, 2021
Translation in Brief

Lentigen’s trispecific CAR Ts; plus a bispecific antiviral COVID-19 mAb, Wild Biotech, Kancera and more

...The mAb —developed by scientists from the Institute for Research in Biomedicine...
...Vascular endothelial growth factor C Danielle Golovin AZD8797, KAND567, KAN0440567 Institute for Research in Biomedicine Academy...
BioCentury | Jun 16, 2020
Finance

Barcelona’s Ona takes aim at metastasis with €30M series A

...program can be first in class. Based on research by co-founder Salvador Aznar-Benitah at the Institute for Research in Biomedicine...
BioCentury | Mar 14, 2020
Product Development

AbCellera, Vir find partners for COVID-19 mAb manufacturing capacity

...proven itself in the fight against another emerging pathogen, Ebola. Teams at Humabs and the Institute for Research in Biomedicine...
BioCentury | Jul 11, 2019
Targets & Mechanisms

The tumor stroma rises as the newest source of immuno-oncology targets

...immune and stromal cellular players in this space,” she said. A separate team from the Institute for Research in Biomedicine...
...NYSE:LLY), Indianapolis, Ind. Genentech Inc., South San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Institute for Research in Biomedicine...
BioCentury | Mar 19, 2019
Distillery Therapeutics

RSV F protein-based nanoparticle vaccine for RSV infection

...Marcandalli, J. et al. Cell ; published online Mar. 7, 2019 doi:10.1016/j.cell.2019.01.046 CONTACT: Laurent Perez, Institute for Research in Biomedicine...
...Switzerland email: laurent.perez@irb.usi.ch CONTACT: Neil P. King, University of Washington, Seattle, Wash. email: neilking@uw.edu Claire Quang Icosavax Inc. Institute for Research in Biomedicine University...
BioCentury | Feb 1, 2019
Clinical News

NIAID says its Ebola therapy is safe

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
BioCentury | Jan 25, 2019
Clinical News

NIAID says its Ebola therapy is safe

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
BioCentury | Dec 6, 2018
Translation in Brief

Opening chromatin: long-term detriment?

...An Institute for Research in Biomedicine team has shown increasing chromatin accessibility in cancer could promote tumor aggressiveness, not reduce...
...and Technology. Sandi Wong, Staff Writer Barcelona Institute of Science and Technology Euchromatic histone-lysine N-methyltransferase 2 (EHMT2) (G9A) Skin cancer chromatin epigenetics Institute for Research in Biomedicine IRB...
BioCentury | Nov 30, 2018
Clinical News

Fauci details goals of new Ebola trial

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
...Status: Phase II start Milestone: NA Steve Usdin GS-5734 mAb114 REGN3470-3471-3479 VSV-EBOV (V920, BPSC1001, rVSV-EBOV, rVSV-ZEBOV-GP, VSV-ZEBOV) Zmapp Gilead Sciences Inc. Humabs BioMed S.A. Institute for Research in Biomedicine Mapp...
BioCentury | Nov 26, 2018
Clinical News

Fauci details goals of new Ebola trial

...on mAb114, which was isolated and characterized by the teams of Antonio Lanzavecchia at the Institute for Research in Biomedicine...
Items per page:
1 - 10 of 26